Close

Momenta Phama's (MNTA) Necuparanib Granted FDA Fast-Track Designation

December 1, 2014 8:16 AM EST Send to a Friend
Momenta Phama (NASDAQ: MNTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login